Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | CTSG | P08311 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | ALKBH1 | Q13686 | 1/20 | 0.31 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3255401 | 0.92 | P2RX7 (0.39) | P2RX7GAACTSLELANECTSG | |
| SCHEMBL3256725 | 0.87 | GAA (0.33) | P2RX7GAATP53RAB9A | |
| SCHEMBL3255413 | 0.84 | ALDH1A1 (0.38) | P2RX7TP53RAB9A | |
| SCHEMBL3255382 | 0.84 | CYP1A2 (0.37) | P2RX7GAARAB9A | |
| SCHEMBL3253786 | 0.84 | GAA (0.33) | P2RX7GAAFFAR4TP53RAB9A | |
| SCHEMBL3256042 | 0.84 | P2RX7 (0.39) | P2RX7GAARAB9A | |
| SCHEMBL3255278 | 0.83 | SIGMAR1 (0.35) | P2RX7GAARIPK1TP53 | |
| SCHEMBL3254884 | 0.83 | SIGMAR1 (0.35) | GRIN2BGAARIPK1TP53 | |
| SCHEMBL3248922 | 0.83 | P2RX7 (0.38) | P2RX7GAACTSLELANECTSG | |
| SCHEMBL3254166 | 0.82 | SMN1; SMN2 (0.39) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651613-B1 | 4,5-DIHYDRO-IMIDAZOLE AS P2X7 ION CHANNEL BLOCKERS | AVENTIS PHARMA INC (US) | 2010-05-26 | — | — | EP | disclosed |